Atualização Científica >> Destaques de Revistas

Efficacy and safety of fenofibric acid in combination with atorvastatin and ezetimibe in patients with mixed dyslipidemia.

Jones PH, Goldberg AC, Knapp HR, Kelly MT, Setze CM, Stolzenbach JC, Sleep DJ. Am Heart J. 2010 Oct;160(4):759-66.

Reclassification of cardiovascular risk using integrated clinical and molecular biosignatures: Design of and rationale for the Measurement to Understand the Reclassification of Disease of Cabarrus and Kannapolis (MURDOCK) Horizon 1 Cardiovascular Disease Study

Shah SH, Granger CB, Hauser ER, Kraus WE, Sun JL, Pieper K, et al; MURDOCK Horizon 1 Cardiovascular Disease Investigators. Am Heart J. 2010 Sep;160(3):371-379.e2.

The BioImage Study: novel approaches to risk assessment in the primary prevention of atherosclerotic cardiovascular disease--study design and objectives.

Muntendam P, McCall C, Sanz J, Falk E, Fuster V; High-Risk Plaque Initiative. Am Heart J. 2010 Jul;160(1):49-57.e1.

Desenvolvido pela Diretoria de Tecnologia da SBC
Todos os Direitos Reservados © Copyright 2015
Sociedade Brasileira de Cardiologia | Tecnologia@cardiol.br